Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
93.50    -0.60 (-0.64%)
Bid:
93.50
Ask:
93.80
Spread: 0.30 (0.321%)
Market Cap: £344.49m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

FY2026 First-Half Trading Update

18 Sep 2025 07:00

RNS Number : 7789Z
C&C Group Plc
18 September 2025
Β 

IMMEDIATE RELEASE

18 September 2025

C&C Group plc

('C&C' or 'the Group')

Β 

FY2026 First-Half Trading Update

Β Earnings in line with expectations

Β 

C&C Group plc today announces that trading in the first half to 31 August 2025, has been in line with expectations. Net Revenues are 4%* below last year, reflecting the impact of lower distribution revenues following the previously disclosed transfer of control of AB InBev Off Trade Beer distribution in the Republic of Ireland and the planned exit of some lower margin business in the period.

Revenues in Matthew Clark Bibendum in the period were slightly below last year, reflecting lower volumes in our national customers in line with market trends, especially within the wines and spirits categories.

Underlying operating profit is expected to be in the range of €41.5-€42.0m, in line with our expectations, reflecting our continued strong focus across cost efficiencies and the continued investment in service, range and value for customers as we continue to build our Distribution business and support the development of our Branded business.

The Group's core brands, Tennent's and Bulmers, delivered solid performances in the period, with both achieving revenue growth. Following the transfer of control of Magners UK back to C&C Group in January 2025, we have commenced our activities to re-invigorate the brand. This will be a multi-year programme that has started with a new above-the-line marketing campaign and some initial brand distribution gains in the off trade which have improved performance, offset by continued challenges in the on trade where distribution gains will take more time to be delivered. Our Premium portfolio continues to build distribution in both the on and off trade.

Capital Returns

The Board remains committed to its previously disclosed distribution of €150m to shareholders over the three years to Financial Year 2027 through a combination of progressive dividends and share buybacks. We have now completed the latest €15m tranche of buyback which commenced on 1 May 2025.Β 

To date we have distributed €84m to shareholders since the start of Financial Year 2025.

Outlook

Despite the challenging macroeconomic backdrop, we will continue to invest in the business to improve performance, support growth and ensure we deliver for all our customers and consumers.

Our immediate priorities remain to focus on winning new customers by delivering on our service, range and value proposition, growing market share of core brands, and driving the "Simply Better Growth" simplification programme to deliver efficiency across the organisation.

Whilst the macroeconomic environment remains challenging and we have the all-important Christmas trading period ahead of us, we remain on track to achieve operating profit in line with market expectations.

Β 

*Constant Currency Basis

Β 

Contacts:

C&C Group plc

Roger White, Chief Executive Officer

Andrew Andrea, Chief Financial and Transformation Officer

Email:Β investor.relations@candcgroup.ie

Investors, Analysts & UK Media:

Instinctif Partners

Justine Warren / Tim Pearson

Tel: 020 7457 2020

Email:Β candccapmkts@instinctif.com

Β 

Irish Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 87 707 8379

Email:Β CandCGroup@fticonsulting.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDDLFFEKLXBBE
Date   Source Headline
16th Jun 20265:00 pmRNSDirector/PDMR Shareholding
12th Jun 202610:34 amRNSAnnual Report and Notice of AGM
9th Jun 20264:53 pmRNSHolding(s) in Company
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.